| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | JQ-1:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.051 | 0.1 |
| mRNA | rTRAIL | GDSC1000 | pan-cancer | AAC | -0.052 | 0.1 |
| mRNA | Rapamycin | GDSC1000 | pan-cancer | AAC | -0.074 | 0.1 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.1 |
| mRNA | Bax channel blocker | CTRPv2 | pan-cancer | AAC | -0.057 | 0.1 |
| mRNA | BRD-K96431673 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-K34222889 | CTRPv2 | pan-cancer | AAC | 0.046 | 0.1 |
| mRNA | BRD-K11533227 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |